ADVISORY RESEARCH INC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 142 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.5%.

Quarter-by-quarter ownership
ADVISORY RESEARCH INC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$217,553
-82.9%
4,332
-68.7%
0.03%
+30.4%
Q1 2018$1,269,000
-21.7%
13,834
-35.6%
0.02%
-14.8%
Q4 2017$1,620,000
+36.2%
21,480
+25.9%
0.03%
+42.1%
Q3 2017$1,189,000
-13.5%
17,065
-37.1%
0.02%
-13.6%
Q2 2017$1,375,00027,1370.02%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2017
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders